T(9;22)

Clinical trials for T(9;22) explained in plain language.

Never miss a new study

Get alerted when new T(9;22) trials appear

Sign up with your email to follow new studies for T(9;22), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo tackles resistant leukemia in phase 2 trial

Disease control Recruiting now

This study tests a combination of two drugs—blinatumomab and ponatinib—along with chemotherapy in adults with a specific type of leukemia (Ph-positive ALL) that has come back or not responded to prior treatment. The goal is to see if this approach can improve response rates and s…

Matched conditions: T(9;22)

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 17, 2026 02:45 UTC

T(9;22)

Get alerted when new T(9;22) trials appear

New combo tackles resistant leukemia in phase 2 trial